List of Tables
Table 1. Global Devices for Inhaled Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Devices for Inhaled Medications Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Devices for Inhaled Medications Market Competitive Situation by Manufacturers in 2024
Table 4. Global Devices for Inhaled Medications Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Devices for Inhaled Medications Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Devices for Inhaled Medications Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Devices for Inhaled Medications Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Devices for Inhaled Medications, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Devices for Inhaled Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Devices for Inhaled Medications, Product Type & Application
Table 12. Global Key Manufacturers of Devices for Inhaled Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Devices for Inhaled Medications as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Devices for Inhaled Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Devices for Inhaled Medications Sales by Region (2020-2025) & (K Units)
Table 18. Global Devices for Inhaled Medications Sales Market Share by Region (2020-2025)
Table 19. Global Devices for Inhaled Medications Sales by Region (2026-2031) & (K Units)
Table 20. Global Devices for Inhaled Medications Sales Market Share by Region (2026-2031)
Table 21. Global Devices for Inhaled Medications Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Devices for Inhaled Medications Revenue Market Share by Region (2020-2025)
Table 23. Global Devices for Inhaled Medications Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Devices for Inhaled Medications Revenue Market Share by Region (2026-2031)
Table 25. North America Devices for Inhaled Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Devices for Inhaled Medications Sales by Country (2020-2025) & (K Units)
Table 27. North America Devices for Inhaled Medications Sales by Country (2026-2031) & (K Units)
Table 28. North America Devices for Inhaled Medications Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Devices for Inhaled Medications Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Devices for Inhaled Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Devices for Inhaled Medications Sales by Country (2020-2025) & (K Units)
Table 32. Europe Devices for Inhaled Medications Sales by Country (2026-2031) & (K Units)
Table 33. Europe Devices for Inhaled Medications Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Devices for Inhaled Medications Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Devices for Inhaled Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Devices for Inhaled Medications Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Devices for Inhaled Medications Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Devices for Inhaled Medications Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Devices for Inhaled Medications Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Devices for Inhaled Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Devices for Inhaled Medications Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Devices for Inhaled Medications Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Devices for Inhaled Medications Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Devices for Inhaled Medications Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Devices for Inhaled Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Devices for Inhaled Medications Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Devices for Inhaled Medications Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Devices for Inhaled Medications Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Devices for Inhaled Medications Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Devices for Inhaled Medications Sales (K Units) by Type (2020-2025)
Table 51. Global Devices for Inhaled Medications Sales (K Units) by Type (2026-2031)
Table 52. Global Devices for Inhaled Medications Sales Market Share by Type (2020-2025)
Table 53. Global Devices for Inhaled Medications Sales Market Share by Type (2026-2031)
Table 54. Global Devices for Inhaled Medications Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Devices for Inhaled Medications Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Devices for Inhaled Medications Revenue Market Share by Type (2020-2025)
Table 57. Global Devices for Inhaled Medications Revenue Market Share by Type (2026-2031)
Table 58. Global Devices for Inhaled Medications Price (USD/Unit) by Type (2020-2025)
Table 59. Global Devices for Inhaled Medications Price (USD/Unit) by Type (2026-2031)
Table 60. Global Devices for Inhaled Medications Sales (K Units) by Application (2020-2025)
Table 61. Global Devices for Inhaled Medications Sales (K Units) by Application (2026-2031)
Table 62. Global Devices for Inhaled Medications Sales Market Share by Application (2020-2025)
Table 63. Global Devices for Inhaled Medications Sales Market Share by Application (2026-2031)
Table 64. Global Devices for Inhaled Medications Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Devices for Inhaled Medications Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Devices for Inhaled Medications Revenue Market Share by Application (2020-2025)
Table 67. Global Devices for Inhaled Medications Revenue Market Share by Application (2026-2031)
Table 68. Global Devices for Inhaled Medications Price (USD/Unit) by Application (2020-2025)
Table 69. Global Devices for Inhaled Medications Price (USD/Unit) by Application (2026-2031)
Table 70. Consort Medical Company Information
Table 71. Consort Medical Description and Business Overview
Table 72. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Consort Medical Devices for Inhaled Medications Product
Table 74. Consort Medical Recent Developments/Updates
Table 75. Inhalexper Company Information
Table 76. Inhalexper Description and Business Overview
Table 77. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Inhalexper Devices for Inhaled Medications Product
Table 79. Inhalexper Recent Developments/Updates
Table 80. Cambridge Consultants Company Information
Table 81. Cambridge Consultants Description and Business Overview
Table 82. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Cambridge Consultants Devices for Inhaled Medications Product
Table 84. Cambridge Consultants Recent Developments/Updates
Table 85. Hovione Company Information
Table 86. Hovione Description and Business Overview
Table 87. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Hovione Devices for Inhaled Medications Product
Table 89. Hovione Recent Developments/Updates
Table 90. Catalent, Inc Company Information
Table 91. Catalent, Inc Description and Business Overview
Table 92. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Catalent, Inc Devices for Inhaled Medications Product
Table 94. Catalent, Inc Recent Developments/Updates
Table 95. VertMarkets, Inc Company Information
Table 96. VertMarkets, Inc Description and Business Overview
Table 97. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. VertMarkets, Inc Devices for Inhaled Medications Product
Table 99. VertMarkets, Inc Recent Developments/Updates
Table 100. Qualicaps Company Information
Table 101. Qualicaps Description and Business Overview
Table 102. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Qualicaps Devices for Inhaled Medications Product
Table 104. Qualicaps Recent Developments/Updates
Table 105. 3M Company Information
Table 106. 3M Description and Business Overview
Table 107. 3M Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. 3M Devices for Inhaled Medications Product
Table 109. 3M Recent Developments/Updates
Table 110. Aerovance Company Information
Table 111. Aerovance Description and Business Overview
Table 112. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Aerovance Devices for Inhaled Medications Product
Table 114. Aerovance Recent Developments/Updates
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. AstraZeneca Devices for Inhaled Medications Product
Table 119. AstraZeneca Recent Developments/Updates
Table 120. Boehringer Ingelheim Company Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Boehringer Ingelheim Devices for Inhaled Medications Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Chiesi Company Information
Table 126. Chiesi Description and Business Overview
Table 127. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Chiesi Devices for Inhaled Medications Product
Table 129. Chiesi Recent Developments/Updates
Table 130. Cipla Company Information
Table 131. Cipla Description and Business Overview
Table 132. Cipla Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Cipla Devices for Inhaled Medications Product
Table 134. Cipla Recent Developments/Updates
Table 135. Civitas/Alkermes Company Information
Table 136. Civitas/Alkermes Description and Business Overview
Table 137. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Civitas/Alkermes Devices for Inhaled Medications Product
Table 139. Civitas/Alkermes Recent Developments/Updates
Table 140. GlaxoSmithKline Company Information
Table 141. GlaxoSmithKline Description and Business Overview
Table 142. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. GlaxoSmithKline Devices for Inhaled Medications Product
Table 144. GlaxoSmithKline Recent Developments/Updates
Table 145. Hovione Company Information
Table 146. Hovione Description and Business Overview
Table 147. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Hovione Devices for Inhaled Medications Product
Table 149. Hovione Recent Developments/Updates
Table 150. Mannkind Company Information
Table 151. Mannkind Description and Business Overview
Table 152. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Mannkind Devices for Inhaled Medications Product
Table 154. Mannkind Recent Developments/Updates
Table 155. Mantecorp Company Information
Table 156. Mantecorp Description and Business Overview
Table 157. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Mantecorp Devices for Inhaled Medications Product
Table 159. Mantecorp Recent Developments/Updates
Table 160. Meda Company Information
Table 161. Meda Description and Business Overview
Table 162. Meda Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Meda Devices for Inhaled Medications Product
Table 164. Meda Recent Developments/Updates
Table 165. MicroDose Therapeutx Company Information
Table 166. MicroDose Therapeutx Description and Business Overview
Table 167. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. MicroDose Therapeutx Devices for Inhaled Medications Product
Table 169. MicroDose Therapeutx Recent Developments/Updates
Table 170. Novartis Company Information
Table 171. Novartis Description and Business Overview
Table 172. Novartis Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Novartis Devices for Inhaled Medications Product
Table 174. Novartis Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Devices for Inhaled Medications Distributors List
Table 178. Devices for Inhaled Medications Customers List
Table 179. Devices for Inhaled Medications Market Trends
Table 180. Devices for Inhaled Medications Market Drivers
Table 181. Devices for Inhaled Medications Market Challenges
Table 182. Devices for Inhaled Medications Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Devices for Inhaled Medications
Figure 2. Global Devices for Inhaled Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Devices for Inhaled Medications Market Share by Type: 2024 & 2031
Figure 4. Dry Powder Inhalers Product Picture
Figure 5. Metered-Dose Inhalers Product Picture
Figure 6. Nebulizers Product Picture
Figure 7. Soft Mist Inhaler Product Picture
Figure 8. Global Devices for Inhaled Medications Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Devices for Inhaled Medications Market Share by Application: 2024 & 2031
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Household
Figure 13. Global Devices for Inhaled Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Devices for Inhaled Medications Market Size (2020-2031) & (US$ Million)
Figure 15. Global Devices for Inhaled Medications Sales (2020-2031) & (K Units)
Figure 16. Global Devices for Inhaled Medications Average Price (USD/Unit) & (2020-2031)
Figure 17. Devices for Inhaled Medications Report Years Considered
Figure 18. Devices for Inhaled Medications Sales Share by Manufacturers in 2024
Figure 19. Global Devices for Inhaled Medications Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Devices for Inhaled Medications Players: Market Share by Revenue in Devices for Inhaled Medications in 2024
Figure 21. Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Devices for Inhaled Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Devices for Inhaled Medications Sales Market Share by Country (2020-2031)
Figure 24. North America Devices for Inhaled Medications Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Devices for Inhaled Medications Sales Market Share by Country (2020-2031)
Figure 28. Europe Devices for Inhaled Medications Revenue Market Share by Country (2020-2031)
Figure 29. Germany Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Devices for Inhaled Medications Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Devices for Inhaled Medications Revenue Market Share by Region (2020-2031)
Figure 36. China Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Devices for Inhaled Medications Sales Market Share by Country (2020-2031)
Figure 47. Latin America Devices for Inhaled Medications Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Devices for Inhaled Medications Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Devices for Inhaled Medications Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Devices for Inhaled Medications Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Devices for Inhaled Medications by Type (2020-2031)
Figure 57. Global Revenue Market Share of Devices for Inhaled Medications by Type (2020-2031)
Figure 58. Global Devices for Inhaled Medications Price (USD/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Devices for Inhaled Medications by Application (2020-2031)
Figure 60. Global Revenue Market Share of Devices for Inhaled Medications by Application (2020-2031)
Figure 61. Global Devices for Inhaled Medications Price (USD/Unit) by Application (2020-2031)
Figure 62. Devices for Inhaled Medications Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
